tiprankstipranks
Trending News
More News >
Cardiol Therapeutics (CRDL)
NASDAQ:CRDL
US Market

Cardiol Therapeutics (CRDL) Financial Statements

Compare
611 Followers

Cardiol Therapeutics Financial Overview

Cardiol Therapeutics's market cap is currently $98.59M. The company's EPS TTM is $-0.08639244; its P/E ratio is -3.21; Cardiol Therapeutics is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 78.76KC$ 0.00
Gross ProfitC$ -373.11KC$ -248.35KC$ -219.91KC$ 78.76KC$ -229.54K
Operating IncomeC$ -40.28MC$ -29.79MC$ -50.34MC$ -45.47MC$ -20.61M
EBITDAC$ -36.30MC$ -27.88MC$ -30.71MC$ -38.44MC$ -20.41M
Net IncomeC$ -36.68MC$ -28.13MC$ -11.52MC$ -24.72MC$ -20.65M
Balance Sheet
Cash & Short-Term InvestmentsC$ 30.58MC$ 34.93MC$ 59.47MC$ 83.90MC$ 14.03M
Total AssetsC$ 31.86MC$ 36.70MC$ 62.03MC$ 87.88MC$ 15.89M
Total DebtC$ 158.53KC$ 158.53KC$ 72.87KC$ 117.58KC$ 156.57K
Net DebtC$ -30.42MC$ -34.77MC$ -59.40MC$ -83.78MC$ -13.87M
Total LiabilitiesC$ 7.14MC$ 8.45MC$ 9.83MC$ 11.64MC$ 2.62M
Stockholders' EquityC$ 24.73MC$ 28.25MC$ 52.20MC$ 76.24MC$ 13.27M
Cash Flow
Free Cash FlowC$ -25.08M-C$ -27.30MC$ -23.56MC$ -9.23M
Operating Cash FlowC$ -25.06M-C$ -27.22MC$ -23.55MC$ -9.19M
Investing Cash FlowC$ -21.29KC$ -64.31KC$ -74.71KC$ -12.92KC$ -40.60K
Financing Cash FlowC$ 18.84M-C$ -53.93KC$ 93.44MC$ 16.30M
Currency in CAD

Cardiol Therapeutics Earnings and Revenue History

Cardiol Therapeutics Debt to Assets

Cardiol Therapeutics Cash Flow

Cardiol Therapeutics Forecast EPS vs Actual EPS